Shanghai MicroPort EP Medtech Co (SHSE:688351) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688351 Shanghai MicroPort EP Medtech Co Ltd SHSE:688351
76 GF Score
Price ¥17.85
GF Value ¥27.60
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai MicroPort EP Medtech Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Shanghai MicroPort EP Medtech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥40.1 Mil. Shanghai MicroPort EP Medtech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥1.6 Mil. Shanghai MicroPort EP Medtech Co's annualized EBITDA for the quarter that ended in Jun. 2026 was ¥90.2 Mil. Shanghai MicroPort EP Medtech Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 0.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:688351' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.24   Med: 0.73   Max: 4.16
Current: 0.08

During the past 7 years, the highest Debt-to-EBITDA Ratio of Shanghai MicroPort EP Medtech Co was 4.16. The lowest was -7.24. And the median was 0.73.

SHSE:688351's Debt-to-EBITDA is ranked better than
92.36% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 1.64 vs SHSE:688351: 0.08

Shanghai MicroPort EP Medtech Co  (SHSE:688351) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Shanghai MicroPort EP Medtech Co Debt-to-EBITDA Related Terms


Shanghai MicroPort EP Medtech Co Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai MicroPort EP Medtech Co Debt-to-EBITDA Chart

Shanghai MicroPort EP Medtech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial - - - - -

Shanghai MicroPort EP Medtech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:688351 vs ABT, SYK, MDT: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicroPort EP Medtech Co Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA falls into.


SHSE:688351
76GF Score
Shanghai MicroPort EP Medtech Co Ltd SHSE:688351
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai MicroPort EP Medtech Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Shanghai MicroPort EP Medtech Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(34.17742735 + 0.55965237) / 92.5341568
=0.38

Shanghai MicroPort EP Medtech Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(40.08727662 + 1.61451824) / 90.22174154
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Shanghai MicroPort EP Medtech Co (SHSE:688351) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai MicroPort EP Medtech Co stock appears to be undervalued. The current stock price of ¥17.85 is trading 35.3% below its estimated GF Value™ of ¥27.60. GuruFocus considers Shanghai MicroPort EP Medtech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688351:

  • Debt-to-EBITDA:
  • GF Value™: ¥27.60 vs. price of ¥17.85 (35.3% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai MicroPort EP Medtech Co Business Description

Address No. 1-28, Lane 588, Tianxiong Road, Building 28, Zhoupu Town, Pudong New Area, Shanghai, CHN, 201318
Shanghai MicroPort EP Medtech Co Ltd is engaged in the research, development, production and sales of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment.
76GF Score

Get the complete analysis for SHSE:688351

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.85
Price
¥27.60
GF Value